CHEK2 and breast cancer: An interesting report by Zhao and colleagues [226] described a Chinese family with the germline CHEK2 mutation c.417A>C (p.Y139*; described independently as a recurrent germline mutation in Chinese breast cancer patients [142]) segregating in all four first-degree relatives with papillary thyroid cancer.